AU2002216009A1 - Clinical and functional validation of targets from disseminated cancer cells - Google Patents

Clinical and functional validation of targets from disseminated cancer cells

Info

Publication number
AU2002216009A1
AU2002216009A1 AU2002216009A AU1600902A AU2002216009A1 AU 2002216009 A1 AU2002216009 A1 AU 2002216009A1 AU 2002216009 A AU2002216009 A AU 2002216009A AU 1600902 A AU1600902 A AU 1600902A AU 2002216009 A1 AU2002216009 A1 AU 2002216009A1
Authority
AU
Australia
Prior art keywords
targets
clinical
cancer cells
functional validation
disseminated cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216009A
Inventor
Beatrix Boeckmann
Michael Giesing
Hans-Jorg Grill
Bernhard Suchy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000154635 external-priority patent/DE10054635A1/en
Application filed by Individual filed Critical Individual
Publication of AU2002216009A1 publication Critical patent/AU2002216009A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002216009A 2000-11-03 2001-11-05 Clinical and functional validation of targets from disseminated cancer cells Abandoned AU2002216009A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24585400P 2000-11-03 2000-11-03
DE10054635.8 2000-11-03
US60/245,854 2000-11-03
DE2000154635 DE10054635A1 (en) 2000-11-03 2000-11-03 Clinically validating target from disseminated cancer cells by determining whether status of target determined in cancer cells of individuals correlates with cancer-related information about clinical status of individuals
PCT/EP2001/012786 WO2002037113A2 (en) 2000-11-03 2001-11-05 Clinical and functional validation of targets from disseminated cancer cells

Publications (1)

Publication Number Publication Date
AU2002216009A1 true AU2002216009A1 (en) 2002-05-15

Family

ID=26007559

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216009A Abandoned AU2002216009A1 (en) 2000-11-03 2001-11-05 Clinical and functional validation of targets from disseminated cancer cells

Country Status (2)

Country Link
AU (1) AU2002216009A1 (en)
WO (1) WO2002037113A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008505644A (en) * 2004-07-09 2008-02-28 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション Identification of markers in esophageal cancer, colon cancer, head and neck cancer, and melanoma
EP1803822A1 (en) * 2005-12-30 2007-07-04 Adnagen AG Method for the individual characterization of therapeutic target molecules and use thereof
EP2245460B1 (en) * 2008-01-25 2013-12-25 Berg LLC Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy
DK3147373T3 (en) 2010-07-27 2019-08-12 Genomic Health Inc METHOD OF APPLYING GENEPRESSION TO DETERMINE THE PROSTATE CANCER FORECAST
EP3199641B1 (en) 2016-01-27 2021-09-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Means and methods for staging, typing and treating a cancerous disease

Also Published As

Publication number Publication date
WO2002037113A2 (en) 2002-05-10
WO2002037113A3 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2001264559A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
AU2001229682A1 (en) Small cell lung cancer associated antigens and uses therefor
AU2001294943A1 (en) Nucleic acid sequences differentially expressed in cancer tissue
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU1339701A (en) Anti-cancer nucleic acid and protein targets
AU1922301A (en) Differential gene expression in cancer
AUPQ923100A0 (en) Treatment of prostate cancer
AU2002362463A1 (en) Treatment of uterine serous papillary cancer
AU2002319338A1 (en) Cancer specific oligosaccharide sequences and use thereof
AU2001268467A1 (en) Identification of genes and compounds for treatment of cancer
AU2001267428A1 (en) Direct detection of individual molecules
AU2002360345A1 (en) Prostate cancer genes
AU2002356898A1 (en) Gene amplification and overexpression in cancer
AU2002342053A1 (en) Pancreatic cancer diagnosis and therapies
AU6387000A (en) Serial analysis of genetic alterations
AU2002216009A1 (en) Clinical and functional validation of targets from disseminated cancer cells
AU2709401A (en) Detection of biological target
AU8026300A (en) Sodd gene expression in cancer
AU2001278068A1 (en) Methods and compositions for predicting prostate cancer
AU5140400A (en) Assay for the detection of paclitaxel resistant cells in human tumors
AU2001288985A1 (en) Uses of mammalian genes and related reagents
AU2001284265A1 (en) Genetic study
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001280891A1 (en) Uses of mammalian genes and related reagents
AU2001288940A1 (en) Gene and sequence variation associated with cancer